Srijita Dhar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Srijita Dhar has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Abdulsalam Abu-Libdeh
Department of Pediatrics, Division of Pediatric Endocrinology, Makassed Hospital and Al-Quds Medical School, Jerusalem, Palestinian Territory, Occupied
1 shared publication - Anil N. Ganesh
Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK
1 shared publication - Arindam Datta
Translational Gerontology Branch, National Institute on Aging, NIH, Baltimore, Maryland, USA
1 shared publication - Bassam Abu-Libdeh
Department of Pediatrics and Genetics, Makassed Hospital and Al-Quds Medical School, East Jerusalem, Palestine
1 shared publication - Beth Louise Woodward
University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK
1 shared publication - Claudia M. Nicolae
Department of Molecular and Precision Medicine, The Pennsylvania State University College of Medicine , Hershey, PA 17033
1 shared publication
Latest Publications
- Open Access
- 1 March 2022
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 132 (5)
RECON syndrome is a genome instability disorder caused by mutations in the DNA helicase RECQL1
Despite being the first homolog of the bacterial RecQ helicase to be identified in humans, the function of RECQL1 remains poorly characterized. Furthermore, unlike other members of the human RECQ family of helicases, mutations in RECQL1 have not been associated with a genetic disease. Here, we identify 2 families with a genome instability disorder that we have named RECON (RECql ONe) syndrome, caused by biallelic mutations in the RECQL gene. The affected individuals had short stature, progeroid facial features, a hypoplastic nose, xeroderma, and skin photosensitivity and were homozygous for the same missense mutation in RECQL1 (p.Ala459Ser), located within its zinc binding domain. Biochemical analysis of the mutant RECQL1 protein revealed that the p.A459S missense mutation compromised its ATPase, helicase, and fork restoration activity, while its capacity to promote single-strand DNA annealing was largely unaffected. At the cellular level, this mutation in RECQL1 gave rise to a defect in the ability to repair DNA damage induced by exposure to topoisomerase poisons and a failure of DNA replication to progress efficiently in the presence of abortive topoisomerase lesions. Taken together, RECQL1 is the fourth member of the RecQ family of helicases to be associated with a human genome instability disorder.
- 1 March 2022
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 132 (5)
Open AccessRECON syndrome is a genome instability disorder caused by mutations in the DNA helicase RECQL1
Despite being the first homolog of the bacterial RecQ helicase to be identified in humans, the function of RECQL1 remains poorly characterized. Furthermore, unlike other members of the human RECQ family of helicases, mutations in RECQL1 have not been associated with a genetic disease. Here, we identify 2 families with a genome instability disorder that we have named RECON (RECql ONe) syndrome, caused by biallelic mutations in the RECQL gene. The affected individuals had short stature, progeroid facial features, a hypoplastic nose, xeroderma, and skin photosensitivity and were homozygous for the same missense mutation in RECQL1 (p.Ala459Ser), located within its zinc binding domain. Biochemical analysis of the mutant RECQL1 protein revealed that the p.A459S missense mutation compromised its ATPase, helicase, and fork restoration activity, while its capacity to promote single-strand DNA annealing was largely unaffected. At the cellular level, this mutation in RECQL1 gave rise to a defect in the ability to repair DNA damage induced by exposure to topoisomerase poisons and a failure of DNA replication to progress efficiently in the presence of abortive topoisomerase lesions. Taken together, RECQL1 is the fourth member of the RecQ family of helicases to be associated with a human genome instability disorder.